Data analytics firm Palantir (PLTR) is the top-performing stock in the benchmark S&P 500 index so far this year.

Pliant (PLRX) stock plunged 61% on news it has paused enrollment in a Phase 2b study of its drug bexotegrast in patients with ...

We recently compiled a list of the 13 Best Natural Gas and Oil Dividend Stocks To Buy. In this article, we are going to take a look at where BP p.l.c.

Needham analyst Joseph Stringer lowered the firm’s price target on Pliant Therapeutics (PLRX) to $10 from $38 and keeps a Buy rating on the ...

Pliant Therapeutics halted new enrollment in its BEACON-IPF trial after a safety board review. A separate study showed ...

Palantir's Q4 earnings beat expectations, with revenue up 36% YoY and EPS up 75% YoY. Check out why I remain bearish on PLTR ...

The result has been tremendous growth. Just four years ago, Palantir had 14 U.S. commercial customers. Today, that number has ...

LLY is reporting earnings tomorrow and the options market predicts major moves. PFP system shows bullish positioning and ...

Prabhudas Lilladher recommended reduce rating on Petronet LNG with a target price of Rs 276 in its research report dated ...

Netflix Inc. is raising prices again — though for some viewers, it’s actually been some time since the last hike. The company announced alongside its earnings Tuesday afternoon that it will be ...

The company may buy the shares directly or offer shareholders the option of tendering their shares at a fixed price. Share repurchases automatically increase the earnings per share (EPS ...

The shares of HDFC Bank were trading today at 10.55 a.m. on the NSE at ₹1,658.10, down ₹7.95 or 0.48 per cent. HDFC Bank reported a modest 2 per cent year-on-year increase in net profit for ...